Related Experiment Video

Updated: Jun 2, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Rapid killing of urothelial carcinoma-cells by wild-type p53

D Makri1, W Schulz, M Grimm

  • 1UNIV DUSSELDORF,INST PHYSIOL CHEM 1,D-40001 DUSSELDORF,GERMANY. UNIV DUSSELDORF,UROL KLIN,D-40001 DUSSELDORF,GERMANY.

International Journal of Oncology
|May 10, 2011
PubMed

Insights

Reintroducing wild-type p53 protein effectively eliminates urothelial carcinoma cells, regardless of their specific p53 gene mutations. This finding offers potential new therapeutic strategies for bladder cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Urothelial carcinoma, a type of bladder cancer, is often associated with mutations in the p53 tumor suppressor gene.
  • The role of wild-type p53 in regulating cell growth and death is critical for preventing cancer development.

Purpose of the Study:

  • To investigate the effect of reintroducing wild-type p53 on urothelial carcinoma cells with existing p53 mutations.
  • To determine if wild-type p53 expression can induce cell death in these cancer cells.

Main Methods:

  • Transfection of six urothelial carcinoma cell lines with varying p53 mutations using a wild-type p53 expression construct.
  • Co-transfection with resistance plasmids to assess cell survival.
  • Cytochemical analysis to observe cell viability and disappearance post-transfection.

Main Results:

  • Co-transfection with wild-type p53 (pCMVhup53) significantly reduced the number of neomycin-resistant cell clones compared to control vectors.
  • Cells expressing wild-type p53 showed rapid disappearance within two days after transfection.
  • These effects were observed across all tested cell lines, irrespective of their p53 mutation status.

Conclusions:

  • Re-expression of wild-type p53 is a potent inducer of cell death in urothelial carcinoma cells.
  • The tumor-suppressive function of wild-type p53 is effective even in the presence of diverse p53 mutations within the cancer cells.
  • This suggests a potential therapeutic strategy for targeting urothelial carcinomas by restoring wild-type p53 function.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...